Concentrated Cruciferous Compound Cuts Cancer
A common blood cancer in children is called acute lymphoblastic leukemia. Most children are cured of the cancer. About one in five kids, though, don’t respond to treatment. A natural alternative may help these youngsters.
Treating Cancer in Very High Risk Kids
Remarkable progress has been made in treating childhood leukemia. Many kids who get these blood cancers will beat their disease and live normal lives. Progress is being made in treating a more aggressive and life-threatening form of pediatric leukemia.
Attacking Leukemia Resistance
Chronic myeloid leukemia ( CML ) is a tricky cancer because it can respond well to initial therapy, but then that drug sometimes stops working. The same thing can happen when different – second-line – drugs are used. The reason for this is that the disease tends to keep changing or mutating.
Cheers Against Blood Cancers
You’ve probably heard that red wine is good for you. And maybe you’ve also heard that drinking can increase your risks of specific types of cancer. A recent review puts a checkmark in the “alcohol-healthy” column.
Decoding an ALL Mighty Cancer
One type of blood cancer is fairly common in children. It’s called acute lymphoblastic leukemia, or ALL for short. Most children are cured of this cancer. In adults, though, ALL is far more ferocious.
A Call to Change the Standard
Blood cancers, including leukemia and lymphoma, are sometimes treated with bone marrow transplants. The therapy uses stem cells to replace blood cells damaged by the cancer.
New Chronic Leukemia Drug Approved
A new medication for chronic myelogenous leukemia ( CML ) has been approved by the US Food and Drug Administration.
Leukemia Drug Granted Accelerated Review
The U.S. Food and Drug Administration has granted Ariad Pharmaceuticals, Inc. accelerated review of its drug ponatinib to treat patients who have chronic myeloid leukemia ( CML ) that doesn’t respond to current medications.
Former Senator Arlen Specter Dies
The Senator who served the state of Pennsylvania for longer than anyone in history – Arlen Specter – has lost his years-long battle with cancer. He died of complications from non-Hodgkin's lymphoma (NHL) in his Philadelphia home this morning.
Recycling the Cyclin D1 Target Theory
Non-Hodgkin lymphoma is a cancer that starts in the lymphatic system, that’s made up of tiny tubes that run throughout the body. One subtype of non-Hodgkin lymphoma (NHL) – mantle cell lymphoma – needs more treatment options and research is under way to find those solutions.